8.5.2024
7.5.2024
14
May
2024
15
Find more news and events
Suomeksi
In English
Finnish Biomedical Imaging Node FiBI has been accepted as a service-providing Node to the pan-European Euro-BioImaging consortium for imaging technologies.
Selected to the Academy of Finland’s Flagship Programme for the years 2020–2024, the GeneCellNano Flagship seeks to speed up the introduction of new biological drugs for severe chronic diseases. The Flagship is led by Academy Professor Seppo Ylä-Herttuala.
The serum metabolite profile can be used to identify individuals likely at risk of developing an alcohol-related disease in the future.
In her doctoral thesis, Prasanthi Medarametla, MSc (Pharm), validated two novel protein targets involved in bacterial infections and found that these alternative drug targets targeting virulence are a better option in current antibiotic resistance crisis.
New sensitive and effective proteomics methods can be applied to identify potential novel drug targets in inflammatory conditions, leukemia and prostate cancer, according to the doctoral dissertation of Joanna Lempiäinen, MSc.
A new study using induced pluripotent stem cell technology links astrocyte dysfunction to Parkinson’s disease pathology.